85-1459-83 BCMA IgG2a Fc, Fusion Protein (B Cell Maturation Protein) 25ug B0807-50B

※お見積書はカートで印刷できます

冷蔵 保管・搬送時に冷蔵が必要な商品です。

特徴

  • The human B cell activating factor (BAFF) and APRIL (a proliferation inducing ligand) are both type II molecules belonging to the TNF superfamily. They are expressed by non-B cells and are down-regulated by mitogenic stimulation. BAFF and APRIL bind to at least two receptors: TACI (transmembrane activator and CAML-interactor) and BCMA (B cell maturation antigen), both of which are restricted to B cells. Ligation of these receptors with recombinant BAFF dramatically increases IgM production by peripheral blood B cells. Recently a third receptor for BAFF (BAFF-R) was described. BAFF and BAFF-R knockout mice have a reduced number of mature B cells in the periphery. However, TACI and BCMA knockouts do not share this phenotype, suggesting that BAFF-R may be the primary receptor for BAFF in mice. Cell surface BAFF can be cleaved to form a soluble trimeric molecule. Levels of soluble BAFF correspond with levels of autoantibodies in Sjogren’s Syndrome. BCMA-muIg binds to recombinant BAFF-muCD8 and can inhibit binding of this molecule to receptors on Raji cells. BCMA IgG2a Fc, Fusion Protein is a soluble molecule consisting of the extracellular domain (54 amino acids) of human BCMA fused to murine IgG2a Fc (232 amino acids).
  • Applications:Suitable for use in ELISA. BCMA-muIg binds to recombinant BAFF-muCD8 and can inhibit this molecule's abiltiy to bind to receptors on Raji cells. Other applications not tested.
  • Recommended Dilutions:Optimal dilutions to be determined by the researcher.
  • Binding Inhibition of Raji Cell Receptors:B0807-50B was tested for its ability to block the binding of B0003-67EX to receptors on Raji cells. 5x10e5 human Raji cells were washed and incubated for 45 min. on ice with 80ul of C2432-01H at 1ug/ml. Cells were washed 2 times and incubated with C2259-11D. Cells were then washed 3 times, fixed and analyzed by FACS. Cells stained positive with a mean shift of 1.3 log10 fluorescent units when compared with a buffer control. This binding was 88% inhibited when B0003-67EX was pre-incubated with 50ug/ml B0807-50B.
  • Storage and Stability:May be stored at 4°C. For long-term storage, aliquot and store at 4°C. Do not freeze. Aliquots are stable for at least 6 months. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:25ug
  • Source Antigen:CHO cells
  • Grade:Affinity Purified
  • Purity:Purified by Protein A affinity chromatography.
  • Form:Supplied as a liquid in 50mM sodium phosphate, pH 7.5, 100mM potassium chloride ,150mM sodium chloride, 0.5mg/ml gentamicin sulfate.
  • Calc Applications Abbrev:E
  • Molecular Weight Non Ab:33
  • EU Commodity Code:38220090
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1459-83
型番
B0807-50B
入り数
1個
標準価格
223,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る